Segui
Federico Biscetti
Federico Biscetti
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Email verificata su policlinicogemelli.it - Home page
Titolo
Citata da
Citata da
Anno
Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line
A Ciccullo, A Borghetti, LZ Dal Verme, A Tosoni, F Lombardi, M Garcovich, ...
International journal of antimicrobial agents 56 (2), 106017, 2020
1622020
Sonic hedgehog regulates angiogenesis and myogenesis during post‐natal skeletal muscle regeneration
G Straface, T Aprahamian, A Flex, E Gaetani, F Biscetti, RC Smith, ...
Journal of cellular and molecular medicine 13 (8b), 2424-2435, 2009
1542009
High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism
F Biscetti, G Straface, R De Cristofaro, S Lancellotti, P Rizzo, V Arena, ...
Diabetes 59 (6), 1496-1505, 2010
1362010
Selective activation of peroxisome proliferator–activated receptor (PPAR) α and PPARγ induces neoangiogenesis through a vascular endothelial growth factor–dependent mechanism
F Biscetti, E Gaetani, A Flex, T Aprahamian, T Hopkins, G Straface, ...
diabetes 57 (5), 1394-1404, 2008
1362008
Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis
A Santoliquido, A Porfidia, A Nesci, G De Matteis, G Marrone, E Porceddu, ...
Journal of Thrombosis and Haemostasis 18 (9), 2358-2363, 2020
1212020
Liver involvement is not associated with mortality: results from a large cohort of SARS‐CoV‐2‐positive patients
FR Ponziani, F Del Zompo, A Nesci, F Santopaolo, G Ianiro, M Pompili, ...
Alimentary pharmacology & therapeutics 52 (6), 1060-1068, 2020
842020
Peroxisome proliferator-activated receptors and angiogenesis
F Biscetti, G Straface, D Pitocco, F Zaccardi, G Ghirlanda, A Flex
Nutrition, Metabolism and Cardiovascular Diseases 19 (11), 751-759, 2009
842009
Sarilumab use in severe SARS-CoV-2 pneumonia
E Gremese, A Cingolani, SL Bosello, S Alivernini, B Tolusso, S Perniola, ...
EClinicalMedicine 27, 2020
832020
Assessment of the genetic effects of polymorphisms in the osteoprotegerin gene, TNFRSF11B, on serum osteoprotegerin levels and carotid plaque vulnerability
G Straface, F Biscetti, D Pitocco, G Bertoletti, M Misuraca, C Vincenzoni, ...
Stroke 42 (11), 3022-3028, 2011
792011
Predicting in‐hospital mortality in COVID‐19 older patients with specifically developed scores
M Covino, G De Matteis, ML Burzo, A Russo, E Forte, A Carnicelli, ...
Journal of the American Geriatrics Society 69 (1), 37-43, 2021
772021
Pro‐inflammatory genetic profiles in subjects with peripheral arterial occlusive disease and critical limb ischemia
A Flex, E Gaetani, F Angelini, A Sabusco, C Chillà, G Straface, F Biscetti, ...
Journal of internal medicine 262 (1), 124-130, 2007
772007
Effect of proinflammatory gene polymorphisms on the risk of Alzheimer's disease
A Flex, S Giovannini, F Biscetti, R Liperoti, G Spalletta, G Straface, F Landi, ...
Neurodegenerative Diseases 13 (4), 230-236, 2014
732014
Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARγ stimulation
F Biscetti, G Straface, V Arena, E Stigliano, G Pecorini, P Rizzo, ...
Cardiovascular Diabetology 8, 1-8, 2009
582009
Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanism
F Biscetti, G Pecorini, G Straface, V Arena, E Stigliano, S Rutella, ...
International journal of cardiology 167 (3), 910-916, 2013
562013
Assessment of neurological manifestations in hospitalized patients with COVID‐19
M Luigetti, R Iorio, AR Bentivoglio, L Tricoli, V Riso, J Marotta, C Piano, ...
European journal of neurology 27 (11), 2322-2328, 2020
542020
Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery disease
F Biscetti, E Nardella, N Bonadia, F Angelini, D Pitocco, A Santoliquido, ...
Cardiovascular diabetology 18, 1-7, 2019
532019
Therapeutic potential of high mobility group box-1 in ischemic injury and tissue regeneration
F Biscetti, G Ghirlanda, A Flex
Current vascular pharmacology 9 (6), 677-681, 2011
522011
Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects
S Giovannini, G Tinelli, F Biscetti, G Straface, F Angelini, D Pitocco, ...
Cardiovascular diabetology 16, 1-9, 2017
512017
COVID-19 and intestinal inflammation: Role of fecal calprotectin
V Ojetti, A Saviano, M Covino, N Acampora, E Troiani, F Franceschi, ...
Digestive and Liver Disease 52 (11), 1231-1233, 2020
492020
Association between TNFRSF11B gene polymorphisms and history of ischemic stroke in Italian diabetic patients
F Biscetti, G Straface, S Giovannini, A Santoliquido, F Angelini, L Santoro, ...
Human genetics 132, 49-55, 2013
482013
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20